Zhi‐Cheng Jing - Concepedia

Author

Zhi‐Cheng Jing

Chinese Academy of Medical Sciences & Peking Union Medical College ORCID

Also Known As

Chun Qiu, David Jimenez, Jian Wang, Jing Zhicheng, Jing, Zhi, Jing, Zhi-Cheng, Jing, Zhicheng, Kubina Jean-Manuel, Kwan Jing Wern, Pavel Jansa

428

Publications

17.5K

Citations

H-Index

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College Fu Wai Hospital Shanghai Pulmonary Hospital Tongji University Peking Union Medical College Hospital

About

Zhi‐Cheng Jing is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	45	3.7K
2	Public Health	25	41	3.4K
3	Health Sciences	2	2	46
4	Engineering	1	1	13
5	Biochemistry	1	1	33

Zhi‐Cheng Jing

117

Publications

10.5K

Citations

H-Index

Page 1

	Year	Citations
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension Tomás Pulido, Igor Adzerikho, Richard N. Channick, New England Journal of Medicine	2013	1.4K
Riociguat for the Treatment of Pulmonary Arterial Hypertension Hossein Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, New England Journal of Medicine	2013	1.3K
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Marc Humbert, Olivier Sitbon, A. Yaïci, European Respiratory Journal	2010	660
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers Marius M. Hoeper, Stephen H. Lee, Robert Voswinckel, Journal of the American College of Cardiology HypertensionHeart FailurePulmonary Arterial HypertensionPulmonary CirculationCardiovascular Disease	2006	601
Clinical features of paediatric pulmonary hypertension: a registry study Rolf M.F. Berger, Maurice Beghetti, Tilman Humpl, The Lancet HypertensionPulmonary Arterial HypertensionCardiovascular DiseasePediatricsPediatric Lung Disease	2012	506
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension Zhi‐Cheng Jing, Keyur Parikh, Tomás Pulido, Circulation	2013	316
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study) Victor F. Tapson, Zhi‐Cheng Jing, Kai‐Feng Xu, CHEST Journal HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicine	2013	290
RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini, The Lancet Respiratory Medicine	2017	262
Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial Hypertension Zhi‐Cheng Jing, Xi‐Qi Xu, Zhi-Yan Han, CHEST Journal HypertensionEpidemiologyPulmonary Arterial HypertensionCardiovascular EpidemiologyCardiovascular Disease	2007	235
Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) Lewis J. Rubin, Nazzareno Galiè, Friedrich Grimminger, European Respiratory Journal	2015	219

Page 1